Tri Locum Partners LP Vir Biotechnology, Inc. Transaction History
Tri Locum Partners LP
- $387 Million
- Q2 2024
A detailed history of Tri Locum Partners LP transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Tri Locum Partners LP holds 30,000 shares of VIR stock, worth $224,700. This represents 0.49% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$224,700% of portfolio
0.49%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VIR
# of Institutions
225Shares Held
87.5MCall Options Held
231KPut Options Held
132K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$125 Million1.37% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$123 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$96.2 Million0.0% of portfolio
-
State Street Corp Boston, MA5.09MShares$38.2 Million0.0% of portfolio
-
Baillie Gifford & CO3.92MShares$29.4 Million0.03% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $993M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...